Serum uric acid in acute myocardial infarction

M Y Nadkar1, V I Jain

  • 1Dept. of Medicine, Seth GS Medical College and KEM Hospital, Parel, Mumbai.

Insights

High uric acid levels in acute myocardial infarction (MI) patients correlate with the severity of heart failure, as indicated by Killip classification. This combination serves as a valuable predictor of mortality post-MI.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Elevated uric acid is a recognized negative prognostic factor in heart failure.
  • Previous studies suggest a correlation between serum uric acid and Killip classification in acute myocardial infarction (MI).

Purpose of the Study:

  • To investigate the relationship between serum uric acid levels and Killip classification in patients with acute myocardial infarction.
  • To assess the predictive value of serum uric acid and Killip class for mortality in acute MI patients.

Main Methods:

  • A study involving 100 patients with acute myocardial infarction and 50 controls.
  • Serum uric acid levels were measured on days 0, 3, and 7 following MI.

Main Results:

  • Patients with acute MI exhibited significantly higher serum uric acid levels on admission compared to controls.
  • Higher serum uric acid levels were observed in patients with a history of MI and in those with higher Killip classifications.
  • All non-survivors (5 patients) after 3 days had serum uric acid levels exceeding 7.0 gm/dL and were classified as Killip class IV.

Conclusions:

  • Serum uric acid levels are elevated in acute MI patients and correlate with Killip class severity.
  • The combined assessment of Killip class and serum uric acid levels post-MI is a robust predictor of patient mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...